Z17.421 is a new billable/specific and POA-exempt diagnosis code introduced in the 2025 ICD-10-CM used to classify the following condition: Hormone receptor negative with human epidermal growth factor receptor 2 negative status.
Inclusion term
HR- with HER2-
TNBC
Triple negative breast cancer
Versions
2025
New code